Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
109.5 USD | -0.27% |
|
+5.76% | +0.19% |
Jul. 08 | Leerink Initiates Revvity at Outperform With $125 Price Target | MT |
Jun. 27 | Barclays Trims Price Target on Revvity to $115 From $116 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.19% | 13.55B | |
+3.26% | 207B | |
+6.55% | 182B | |
+31.66% | 157B | |
+34.32% | 113B | |
+5.13% | 66.91B | |
+19.33% | 55.95B | |
-3.30% | 47.01B | |
-4.84% | 38.17B | |
+3.83% | 36.49B |
- Stock Market
- Equities
- RVTY Stock
- News Revvity, Inc.
- Transcript : Revvity, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 10